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Abstract: 
Financial protection is a core dimension of health system evaluation and several works 
on catastrophic health expenditure (CHE) have been developed. There are however 
some gaps in the literature, hence, this work aims to look at CHE from a different 
angle, following the money spent by households. The objectives are to identify how 
many and which health services are driving CHE and analyse the profile of households 
with CHE. Data come from the Portuguese Household Budget Survey 2015/2016 and 
the study includes 11,398 observations. WHO methodology for CHE identification 
was adopted. Over a fifth of households incurring CHE spent only on medicines and 
this item presented by far the highest expenditures. All families with CHE spent on 
medicines and about two thirds spent on up to three items. Expenditures on medical 
devices and hospital services were low. Dental care expenditures tended to assume 
extreme values. Although primary care services are spread across the country, 
expenditures on GP services were not at all negligible. The typical household with 
CHE consists of an old poor person living alone. Exempting these people from 
medicine co-payments is crucial to prevent catastrophic expenditure.   
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1. Introduction 
 Financial protection was recognised by the World Health Organisation (WHO) as a 
core dimension for the evaluation of health system performance almost two decades 
ago (World Health Organisation, 2000). Later, WHO reinforced the relevance of 
ensuring that everyone is able to access health services and not be subject to financial 
hardship in doing so (World Health Organisation, 2010a). In this line, the framework 
used by WHO to continuously monitor progresses towards universal health coverage 
builds on two main indicators, one of which is the financial protection dimension. The 
financial protection dimension, in turn, has been evaluated through the analysis of 
catastrophic health expenditure (CHE) and impoverishing spending on health. The 
focus of this paper is on CHE, which is out-of-pocket expenditure (OOP) exceeding 
a given threshold of a household’s resources (Wagstaff, 2002; World Health 
Organisation and The World Bank, 2017).  
Despite the relevance of this topic, a recently published systematic review of literature 
(Yerramilli et al., 2018) identified several gaps, concluding that there is scarcity of 
2 
 
up-to-date analysis and no studies drawing on data beyond 2011. These authors also 
point out that identifying the groups who experience financial hardship, while 
breaking down catastrophic out-of-pocket payments by health service is a useful 
starting point for exploring the health system factors that lead to financial hardship. 
The need to address gaps in geographical coverage is also mentioned. The literature 
further shows a bias towards middle-income countries but, although it is acceptable 
to prioritise monitoring in countries with weak financial protection, attention should 
also focus on high income countries. This is so because in some cases the financing 
of health systems relies to a considerable extent on direct payments, putting at risk 
some vulnerable groups of the population, and even countries with strong financial 
protection should be studied in order to identify good practice and highlight 
transferable lessons for policy (Yerramilli et al., 2018).  
One of the limitations of the CHE approach is that some people might not be exposed 
to catastrophic expenditure simply because they are not getting the care they need 
either because they cannot access it or because they cannot afford it (Yerramilli et al., 
2018). Hence, the recommendation by World Health Organisation and The World 
Bank (2017) that financial protection always needs to be jointly monitored with 
service coverage.  
Portugal is an interesting case in the context of this work because it is considered a 
high income country but the share of OOP in total health expenditure is among the 
highest in OECD and EU countries. In 2016, OOP represented 28% of total health 
expenditure in Portugal, which compares to 18% in the EU28 (OECD/EU, 2018). 
Additionally, the country has a National Health Service (NHS), which is universal, 
comprehensive and almost free at point of delivery (according to the Portuguese 
Constitution, Article 64) but there are shortcomings in provision. The NHS 
predominantly provides primary care and specialized hospital care. Dental 
consultations, diagnostic services, renal dialysis and rehabilitation are more 
commonly provided in the private sector (Simões et al., 2017). Typically, the latter 
three services are carried out under contractual arrangements with the NHS.  However 
the NHS does not cover dental care (it is neither provided nor funded by the NHS). 
Most dental care is paid by OOP, as are many specialist consultations in private 
ambulatory care (Thomson et al., 2009; Simões et al., 2017). Regarding 
pharmaceutical expenditure, there are cost-sharing schemes, however, in 2016, 45% 
of the expenditure on retail pharmaceuticals was financed by OOP, compared to 34% 
in the EU28 (OECD/EU, 2018).  
Our objectives are therefore to contribute to the financial protection literature by 
centring the analysis on the types of health care which are absorbing people’s money 
alongside the analysis of the types of health care people are not spending money on.  
Although these aspects have been absent from previous works, they provide relevant 
information, namely how many and which items are driving CHE. We also aim to 
contribute to the literature on financial protection by analysing recent data from a high 
income country and exploring in more detail the profile of households incurring CHE. 
At the same time, we provide evidence that might be used to monitor the financial 






Data were taken from the 2015/2016 wave of the Portuguese Household Budget 
Survey. This survey contains data from a representative stratified clustered sample of 
households living in non-collective dwellings across the country. It was carried out 
by Statistics Portugal. Data were collected in the mainland and islands (Azores and 
Madeira) between 16 March 2015 and 13 March 2016 (INE, 2017). This study 
includes 11,398 observations. 
The variables directly extracted from the database were: total expenditure, food 
expenditure, out-of-pocket health care payments (total and for different types of health 
care considered separately: medicines; other pharmaceutical products, including 
contraception; glasses and contact lenses; hearing devices; other medical devices; 
visits to general practitioners; visits to specialists; dental care; diagnostic tests; 
paramedic services, including ambulance services; hospital services), equivalent 
household size (OECD scale), type of household (one non-elder adult, one elder adult, 
two or more non-elder adults, two or more adults with at least one elder individual 
and no children, one adult with children, two or more adults with one child, two or 
more adults with two or more children), and region of residence (as in Figure 2 – Panel 
2c).  
To identify households with CHE, we adopted the methodology proposed by WHO 
researchers (Xu et al., 2003; Xu, 2005) and followed by several authors (see e.g. 
Yerramilli et al., 2018 for various examples). In this case, a household is said to have 
incurred catastrophic expenditure if its OOP are equal to, or higher than, 40% of its 
capacity to pay. Capacity to pay corresponds to a household’s nonsubsistence 
spending. Subsistence spending is the amount each household is expected to spend on 
food taking into account its equivalent size and the amount spent by the household on 
the sample median food share of total expenditure.  
In a second step, we defined binary variables to identify null expenditures (variables 
assume the value 1 if expenditures are null). Then we considered only households 
with CHE, identifying on how many and on which items they spent their money as 
well as expenditure levels. We further analysed the composition of this group in terms 
of expenditure quintiles, household types and region of residence.   
All the analyses were carried out in SPSS 25.0 and sample weights provided in the 
database were used. 
 
3. Results 
Considering the whole sample, there were 0.46% of households incurring catastrophic 
health expenditure. The prevalence of CHE among the poorest (first expenditure 
quintile) was 1.96%, while it was 0.26% in the second expenditure quintile and 
basically null in the remainder quintiles. In terms of null expenditures, more than 80% 
of families in the whole sample did not spend money on visits to specialists, exams, 
dentists, glasses/lenses and hospital services. More than 90% of all families reported 
no expenditure on other medical devices and paramedic services. Regarding GP visits, 
the percentage of families with no expenditures was about 75%. The lowest 
percentage was found for medicines in which case only 16% of households in the 
whole sample did not spend on this item. The percentage of families reporting null 
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expenditures continuously decreases from the first to the fifth expenditure quintiles 
for all types of health services. In the case of specialist consultations, the percentage 
decreases from 94% to 61%, in the case of dental care it decreases from 93.5% to 
65.5% and for glasses/lenses it decreases from 93% to 71.5%.  
 
Table 1. Destination of payments of households with catastrophic health expenditure 
 Number of items†  













Null expenditures (mean) ‡       
 Medicines 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
 Pharmaceutical products§ 1.0000 0.9304 0.8549 0.9657 0.7254 0.1245 
 Glasses & lenses 1.0000 1.0000 0.6347 0.8360 1.0000 1.0000 
 Hearing devices 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 
 Other medical devices 1.0000 1.0000 0.9159 0.7967 0.3051 0.1245 
 Visits to GP 1.0000 0.4709 0.7023 0.1295 0.9694 0.0000 
 Visits to specialists 1.0000 0.6909 0.7587 0.2338 0.0306 0.0000 
 Dental care 1.0000 0.9779 0.5598 0.9378 0.2746 1.0000 
 Diagnostic tests 1.0000 1.0000 0.8263 0.2998 0.3642 0.8755 
 Paramedics 1.0000 0.9298 0.7067 0.2325 0.3642 0.0000 
 Hospital services 1.0000 1.0000 0.8669 0.9385 0.3307 0.8755 
† Number of items on which households with CHE spend their money 
‡ Binary variables for null expenditures: = 1 if household reports no expenditures 
§ Excluding medicines 
White cells indicate that no family reported expenditures on this item; dark grey cells represent items on 
which at least a quarter of families (in the respective column) spent money on 
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Now, focusing on families with CHE (Table 1) and taking into account where they 
spent their money (for health care), we observe that over a fifth of these households 
incurred catastrophic expenditure by spending on medicines alone. The majority 
(68.5%) spent on up to three items and no family with CHE spent on more than six 
types of health services (from the list presented in section 2). Looking at Table 1, we 
further observe that all families with CHE spent on medicines and none spent on 
hearing devices. Few families with CHE spent on glasses/lenses as well as on hospital 
services and paramedics. Differently, expenditures on GP and specialists 
consultations were more frequently reported.  
A large percentage of households reporting expenditures on a given item does not 
necessarily mean that it is greatly relevant in terms of the financial burden imposed 









Figure 1. Average annual expenditures of households with catastrophic health 
expenditure, according to the number of items on which they spent money 
 
As observed in Figure 1, expenditures on medicines not only were reported by all 
families with CHE but also presented the highest average value (with the exception 
of families spending on 6 items). Although to a lesser extent, specialist and GP 
consultations also attracted important shares of families’ resources. In the case of 




Figure 2. Profile of households (HH) with catastrophic health expenditure (CHE) 
according to household composition (Panel 2a), expenditure quintile (Panel 2b) and 
region of residence (Panel 2c) 
 
The profile in Figure 2 suggests that households with catastrophic expenditure were 
mainly poor elder people living alone in the Centre of the country. Still, about a 
quarter of households with CHE included two or more adults of which at least one 
wass an elder person and 20% of households with CHE lived in the North.  
 
4. Discussion 
In this study we found that 0.46% of Portuguese families incurred catastrophic health 
payments in the period 2015/2016. Compared to 2010/2011, this result represents an 
improvement in financial protection as this percentage was then 2.1% (Quintal and 
Lopes, 2016).  Considering the poorest families (first expenditure quintile), there was 
still an improvement but less pronounced (in this case, the percentage of families with 
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CHE decreased from 4.1% to 1.96%). The value of 0.46% also means that Portugal is 
now aligned with the best performing countries (World Health Organisation, 2010b; 
Yerramilli et al., 2018). Nonetheless, these results should be interpreted with caution 
taking into account that, where the NHS fails to provide health care, the absence of 
spending may represent unmet health care needs. The pattern of null expenditures, 
with always higher prevalence among the poorer groups, supports these concerns.   
A worrying result is the fact that over 20% of families with CHE spent on a single 
item: medicines. Moreover, the average expenditure on medicines among families 
with CHE surpasses 1,400€ reaching a maximum of 4,675€. Average expenditures 
(among families with CHE) for other relevant items such as GP and specialist 
consultations and dental care were between 250€ and 350€. Some results are 
understandable given the characteristics of the Portuguese health system. For 
example, most hospital care is provided within the public sector and we observe that 
mean expenditures for this service was low, both in the whole sample and among 
families with CHE (the maximum value in the whole sample is however much higher). 
The impact of specialist consultations and dental care was also comprehensible as they 
are mainly financed by out-of-pocket payments. However, results regarding 
expenditures on GP visits are rather surprising. Primary care services are spread across 
the country thus individuals with low resources should not feel the need (or should 
not be impelled to) use private care.  
Although the global level of CHE obtained in this study is low, the risk among poor 
families should raise concerns. Authorities have implemented some protective 
measures regarding pharmaceutical expenditure (Simões et al., 2017) but they seem 
to be failing when it comes to poor old people living alone and to some extent to poor 
families with elderly members. Moreover, because there are households incurring 
CHE with few health care services, this means that these expenditures might be 
jeopardising not only the access to other goods and services but also the access to 
needed health care services which are not provided by the NHS. Actually, the 
maximum expenditure on dental care in the whole sample (15,900€) is found precisely 
within the group of families with CHE. This is unexpected given the profile of these 
families. Finally, Portuguese health authorities in the Centre region should be 
particularly attentive to the situation of poor old people. 
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